Loading your page…
Each register with its number of medicines and a few of them.
Health Canada · 3 medicines
FDA · 3 medicines
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Anvisa · 2 medicines
EMA · 2 medicines
CBG-MEB · 2 medicines
AEMPS · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
16 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Awiqli Flextouch | United States | injection | Marketed | Novo Nordisk INC | |
| Awiqli | United States | 700UNITS/ML | Injection | Marketed | Novo Nordisk Inc. |
| Awiqli | United States | 1,050UNITS/1.5ML | Injection | Marketed | Novo Nordisk Inc. |
| KyinsuCombination | European Union | Authorised | Novo Nordisk A/S | ||
| Kyinsu (700 eenheden + 2 mg)/ml oplossing voor injectie in een voorgevulde penCombination | Netherlands | Oplossing voor injectie | Authorised | Novo Nordisk A.S. | |
| Awiqli | European Union | Authorised | Novo Nordisk A/S | ||
| Awiqli 700 eenheden/ml oplossing voor injectie in voorgevulde pen | Netherlands | Oplossing voor injectie | Authorised | Novo Nordisk A.S. | |
| Awiqli 700 Unidades/ML Solucion Inyectable en Pluma Precargada | Spain | 700 UI/ml | solución inyectable en pluma precargada | Authorised | Novo Nordisk A/S |
| KyinsuCombination | Brazil | Authorised | Novo Nordisk Farmacêutica do Brasil Ltda | ||
| Awiqli | Italy | Soluzione iniettabile in penna pre-riempita | Authorised | Novo Nordisk A/S | |
| Awiqli | Canada | 700 UNIT / ML | Solution | Marketed | Novo Nordisk Canada INC |
| Awiqli | Canada | 2100 UNIT / 3 ML | Solution | Marketed | Novo Nordisk Canada INC |
| Awiqli | Canada | 1050 UNIT / 1.5 ML | Solution | Marketed | Novo Nordisk Canada INC |
| KyinsuCombination | Croatia | Authorised | |||
| Awiqli | Brazil | Authorised | Novo Nordisk Farmacêutica do Brasil Ltda | ||
| Awiqli | Croatia | Authorised |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, EMA, FDA, HALMED and Health Canada. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
